Clinical-stage biotechnology company
Appears in 1 story
Developer of RAG-18; presented first-in-human data at WMS 2026
Three boys with Duchenne muscular dystrophy received monthly infusions of an experimental drug. Four months later, muscle biopsies showed 3.5- to 5.3-fold increases in utrophin, a protein that can substitute for the missing dystrophin.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
